scispace - formally typeset
Open AccessJournal Article

Establishment and characterization of a human prostatic carcinoma cell line (PC-3).

M E Kaighn, +4 more
- 01 Jul 1979 - 
- Vol. 17, Iss: 1, pp 16-23
TLDR
The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported, which should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agents.
Abstract
The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported The cultured cells show anchorage-independent growth in both monolayers and in soft agar suspension and produce subcutaneous tumors in nude mice Culture of the transplanted tumor yielded a human cell line with characteristics identical to those used initially to produce the tumor PC-3 has a greatly reduced dependence upon serum for growth when compared to normal prostatic epithelial cells and does not respond to androgens, glucocorticoids, or epidermal or fibroblast gowth factors Karyotypic analysis by quinacrine banding revealed the cells to be completely aneuploid with a modal chromosome number in the hypotriploid range At least 10 distinctive marker chromosomes were identified The overall karyotype as well as the marker chromosomes are distinct from those of the HeLa cell Electron microscopic studies revealed many features common to neoplastic cells of epithelial origin including numerous microvilli, junctional complexes, abnormal nuclei and nucleoli, abnormal mitochondria, annulate lamellae, and lipoidal bodies Overall, the functional and morphologic characteristics of PC-3 are those of a poorly-differentiated adenocarcinoma These cells should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agents

read more

Citations
More filters
Journal ArticleDOI

Oncogenes in prostate cancer. An update.

TL;DR: Current dogma indicates that oncogenes exist in prostate cancer, but these will be identified only by more intensive investigation, and no oncogene has been correlated conclusively with the initiation or progression of prostate cancer.
Journal ArticleDOI

A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49.

TL;DR: A human neuroendocrine/small cell prostate cancer xenograft that was developed from a nodal metastasis of a human prostate carcinoma and that has been propagated as serial subcutaneous implants in severe combined immunodeficient mice for >4 years should prove to be useful in the investigation of mechanisms underlying the androgen-insensitive state of progressive prostate carcinomas.
Journal ArticleDOI

Regulation of vascular endothelial growth factor in prostate cancer

TL;DR: This review examines the essential role for angiogenesis in PCa metastases, and focuses in particular on the current understanding of the regulation of vascular endothelial growth factor (VEGF) in localized and metastatic PCa.
Journal ArticleDOI

Mouse Models in Prostate Cancer Translational Research: From Xenograft to PDX

TL;DR: 3D PDX PCa mouse models show greater fidelity to the disease, in terms of histopathologic features of implanted tumor, gene and miRNA expression, and metastatic pattern, well describing all tumor progression stages; this characteristic encourages the translation of preclinical results.
Journal ArticleDOI

New EGF-R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC-3 and DU-145

TL;DR: The effect of an EGF‐R selective tyrosine kinase inhibitor ZM252868 was evaluated on the proliferation of PC‐3 and DU‐145 prostate cancer cell lines, which are purported to utilize an E GF‐R‐mediated autocrine pathway for regulation of cell growth.
Related Papers (5)